[摘要]目的：观察奥拉西坦与银杏叶提取物注射液同用对急性脑出血患者的影

[Abstract] Objective: To observe 察奥拉西坦 and Ginkgo biloba extract with injection on acute cerebral hemorrhage with. Methods: 112 patients with acute cerebral hemorrhage April 2017 - December 2019 were randomized into treated reference and combined groups, each of the 56 cases, with reference to the treatment group based on the use of conventional therapy Aolaxitan joint group joint Ginkgo biloba extract injection treatment in the reference group based on two groups of patients hypersensitive -C reactive protein (hs-CRP), cell interleukin-6 (IL-6), tumor necrosis factor (TNF-α), etc. serum levels of inflammatory factors; two groups were compared superoxide dismutase (SOD), malondialdehyde (MDA), nitric oxide (NO) and other oxidative stress index; two groups were compared the clinical efficacy. Results: Before treatment, two sets of the comparative levels of inflammatory cytokines and oxidative stress level, no significant difference (all P> 0.05), after treatment, both groups hs-CRP, IL-6, TNF-α, MDA, NO were significantly decreased (P <0.05), and the combination group were significantly lower than the reference group (all P <0.05); two SOD significantly increased (all P <0.05), the combination group was significantly higher than the reference group (P <0.05) ; effective combined treatment group (91.07%) was significantly higher than the reference group (71.43%) (P <0.05). CONCLUSION: Combined Aolaxitan Ginkgo biloba extract Cerebral Hemorrhage can significantly reduce levels of inflammatory factors in patients, to reduce stress and improve clinical outcome.

Purpose: To observe the effect of oxirace and Ginkgo biloba injections on patients with acute cerebral hemorrhage. Methods: 112 patients with acute cerebral hemorrhage were randomly divided into reference group and joint group from April 2017 to December 2019, each 56 cases, the reference group was treated with oxitam on the basis of conventional treatment, and the combined Ginkgo biloba extract injection was treated on the basis of the reference group. Comparing serum inflammatory factor levels such as hypersensitivity-C reactive protein (hs-CRP), cell leukocylic inpatient 6 (IL-6), tumor necrosis factor (TNF-alpha), and two groups of patients with oxidative stress levels such as superoxide dismutase (SOD), propylene dialdehyde (MDA), and nitric oxide (NO) The clinical efficacy of two groups of patients was compared. Results: Prior to treatment, the level of the above-mentioned inflammatory factors and the level of oxidative stress indicators were compared, the difference was not statistically significant (both P.05), and after treatment, the two groups of hs-CRP, IL-6, TNF-alpha, MDA, NoIs both decreased significantly (average P 0.05) and the joint group was significantly lower than the reference group (average P 0.05), the two groups of SOD increased significantly (average P 0.05), the joint group significantly higher than the reference group (P 0.05), and the joint group was significantly more efficient (91.07%) than the reference group (71.43%) ( P.05). Conclusion: The treatment of acute cerebral hemorrhage by Olaxitan in combination with ginkgo biloba extract can significantly reduce the level of inflammatory factors in patients, reduce stress response and improve the effectiveness of clinical treatment.

[Abstract] Objective: To observe the effect of oxiracetam and Ginkgo biloba extract injection on patients with acute cerebral hemorrhage. Methods: 112 patients with acute cerebral hemorrhage from April 2017 to December 2019 were randomly divided into the reference group and the combined group, 56 cases in each group. The reference group was treated with Oxiracetam on the basis of conventional treatment, and the combined group was treated with Ginkgo biloba extract injection on the basis of the reference group. The hypersensitive-c-reactive protein (hs CRP), interleukin-6 (IL-6), tumor were compared between the two groups The levels of serum inflammatory factors such as TNF - α, SOD, MDA and no were compared, and the clinical effects of the two groups were compared. Results: there was no significant difference in the levels of inflammatory factors and oxidative stress between the two groups before and after treatment (P > 0.05) And no decreased significantly (P < 0.05), and SOD increased significantly (P < 0.05) in the combined group and the combined group (P < 0.05), and the effective rate in the combined group was significantly higher (91.07%) than that in the reference group (71.43%) (P < 0.05). Conclusion: oxiracetam combined with Ginkgo biloba extract in the treatment of acute cerebral hemorrhage can significantly reduce the level of inflammatory factors, reduce stress response and improve the clinical treatment effect.<br>